MetaADEDB 2.0 @ LMMD
Polylysine
(NSFPJVJQYCOMBV-UHFFFAOYSA-N)
Structure
SMILES
NCCCC[CH+]C(=O)[NH-]
Molecular Formula:
C6H12N2O
Molecular Weight:
128.172
Log P:
1.5988
Hydrogen Bond Acceptor:
2
Hydrogen Bond Donor:
2
TPSA:
55.12
CAS Number(s):
38000-06-5
Synonym(s)
1.
Polylysine
2.
Epsilon-Polylysine
3.
Poly-(Alpha-L-Lysine)
4.
Epsilon Polylysine
External Link(s)
MeSHD011107
PubChem Compound162282
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Abdominal discomfortOFFSIDES
2AcneOFFSIDES
3Activities of daily living impairedOFFSIDES
4Acute respiratory failureOFFSIDES
5Adenomatous Polyposis ColiOFFSIDES
6AmenorrheaOFFSIDES
7AmnesiaOFFSIDES
8AngerOFFSIDES
9AnorexiaOFFSIDES
10AnxietyOFFSIDES
11AppendicitisOFFSIDES
12ArteritisOFFSIDES
13ArthritisOFFSIDES
14AstheniaOFFSIDES
15AtelectasisOFFSIDES
16Basal cell carcinomaOFFSIDES
17Bipolar DisorderOFFSIDES
18BlepharoptosisOFFSIDES
19Blood GlucoseOFFSIDES
20Blood pressure inadequately controlledOFFSIDES
21Blood urea increasedOFFSIDES
22Blurred visionOFFSIDES
23Bone lesionOFFSIDES
24BronchitisOFFSIDES
25Capillary Leak SyndromeOFFSIDES
26CellulitisOFFSIDES
27Chest PainOFFSIDES
28CryingOFFSIDES
29DependenceOFFSIDES
30Depressed Level of ConsciousnessOFFSIDES
31DizzinessOFFSIDES
32DrowsinessOFFSIDES
33Drug ineffectiveOFFSIDES
34Drug withdrawal headacheOFFSIDES
35Dry skinOFFSIDES
36DyspepsiaOFFSIDES
37DystoniaOFFSIDES
38Electromechanical dissociationOFFSIDES
39EpistaxisOFFSIDES
40Erythema MultiformeOFFSIDES
41ErythemaOFFSIDES
42Esophageal StenosisOFFSIDES
43Euphoric moodOFFSIDES
44FatigueOFFSIDES
45Feeling ColdOFFSIDES
46Feeling abnormalOFFSIDES
47Flank PainOFFSIDES
48FormicationOFFSIDES
49GalactorrheaOFFSIDES
50Gestational DiabetesOFFSIDES
51GlaucomaOFFSIDES
52GlossitisOFFSIDES
53GranulomaOFFSIDES
54Grip strengthOFFSIDES
55Impaired driving abilityOFFSIDES
56Inappropriate schedule of drug administrationOFFSIDES
57Injection site erythemaOFFSIDES
58Intestinal ObstructionOFFSIDES
59Joint stiffnessOFFSIDES
60Kidney FailureOFFSIDES
61Leukopenia neonatalOFFSIDES
62Libido disorderOFFSIDES
63Livedo ReticularisOFFSIDES
64LymphocytosisOFFSIDES
65Mental impairmentOFFSIDES
66Mental status changesOFFSIDES
67Metastases to stomachOFFSIDES
68Musculoskeletal PainOFFSIDES
69NauseaOFFSIDES
70Nervous tensionOFFSIDES
71Neutropenic sepsisOFFSIDES
72Obesity16723640CTD
73OculogyrationOFFSIDES
74Oropharyngeal painOFFSIDES
75PainOFFSIDES
76Pericardial effusionOFFSIDES
77Perirectal abscessOFFSIDES
78PleurisyOFFSIDES
79Pneumocystis jiroveci pneumoniaOFFSIDES
80Post procedural complicationOFFSIDES
81Product quality issueOFFSIDES
82Productive CoughOFFSIDES
83Respiratory tract congestionOFFSIDES
84Retinal DegenerationOFFSIDES
85Sinus bradycardiaOFFSIDES
86SinusitisOFFSIDES
87Skin lesionOFFSIDES
88Stenotrophomonas infectionOFFSIDES
89Stevens-Johnson SyndromeOFFSIDES
90Tardive DyskinesiaOFFSIDES
91Tongue bitingOFFSIDES
92Tongue blisteringOFFSIDES
93Transaminases increasedOFFSIDES
94Unresponsive to stimuliOFFSIDES
95Ventricular FibrillationOFFSIDES
96Vulvovaginal mycotic infectionOFFSIDES
97Weight Gain16723640CTD
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.